论文部分内容阅读
[目的]研究复方丹参片和黄芪精口服液对失代偿期肝硬化患者的日常维持治疗效果,从而探寻提高失代偿期肝硬化患者的生活质量和延长其寿命的有效治疗方法。[方法]选取2006年1月~2008年1月在我院接受长期诊治的失代偿期肝硬化患者68人,随机分为两组,对照组接受传统治疗(护肝、对症、抗病毒治疗),治疗组在传统治疗基础上加用复方丹参片和黄芪精口服液每日口服,治疗时间5~7年,至2013年1月31日截止,统计各组肝硬化并发症发生率和死亡率。[结果]治疗组患者的并发症发生率明显减少,生存时间明显延长,和对照组比较差异有统计学意义(P<0.05)。[结论]复方丹参片和黄芪精口服液口服对失代偿期肝硬化患者有减少并发症和延长生存时间的作用。
[Objective] To study the routine maintenance treatment of compound Danshen Tablets and Huangqi Jing oral liquid on patients with decompensated cirrhosis, so as to explore the effective treatment methods to improve the quality of life and prolong the life of patients with decompensated cirrhosis. [Methods] A total of 68 patients with decompensated cirrhosis undergoing long-term diagnosis and treatment in our hospital from January 2006 to January 2008 were randomly divided into two groups. The control group received conventional therapy (liver protection, symptomatic treatment and antiviral therapy ). The treatment group was treated with Fufang Danshen Tablets and Huangqijing Oral Liquid daily for 5 to 7 years on the basis of the traditional treatment, till January 31, 2013, the incidence of liver cirrhosis complication and death were calculated rate. [Results] The incidence of complications in the treatment group was significantly reduced, the survival time was significantly prolonged, and the difference was statistically significant (P <0.05) compared with the control group. [Conclusion] Oral administration of Fufang Danshen Tablets and Huangqijing Oral Liquid can reduce the complication and extend the survival time of patients with decompensated cirrhosis.